About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

PCM Chinese Edition more

早期三阴性乳腺癌免疫检查点抑制剂回顾

三阴性乳腺癌(triple negative breast... More >>

人类肿瘤中BRAF改变的叙述性综述:诊断和预测意义

B-Raf原癌基因,丝氨酸/苏氨酸激酶( BRAF... More >>

营养影响疾病的潜在分子机制

人体约有50至70万亿个细胞,每个细胞都在高度复杂的生物系统网络中发挥... More >>
Case Report 
The role of concurrent amplification of PD-L1, PD-L2 and JAK2 in metastatic lung adenocarcinoma as a biomarker of immune checkpoint inhibitor response: a case report
William J. Phillips, Arif Awan, Bryan Lo, Andrea Redway, Garth Nicholas
Precision Cancer Medicine  
2023;
6:
10  
Case Report 
Endoscopic endonasal removal of nasal cavity chondrosarcoma extending to the base of the skull: a case report
Nikita I. Mikhailov, Anton M. Zaitsev, Andrew G. Rerberg, Sergei A. Kisarev, Gennadei I. Khokhrikov, Artem E. Lazarev, Olga N. Kirsanova, Tatyana M. Kobyletskaya, Tatiana S. Bezbabicheva, Angelina V. Krivobokova, Peter V. Shegay, Andrey D. Kaprin
Precision Cancer Medicine  
2023;
6:
9  
Review Article 
Radiotherapy in non-surgical management of esophageal cancer in the era of immuno-oncology: a narrative review
Hongcheng Zhu, Jingyi Shen, Mohamed Emam Sobeih, Xinmin Zhao, Huijun Zhu, Kuaile Zhao
Precision Cancer Medicine  
2023;
6:
8  
Review Article 
The use of 18F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review
Eleni Gkika, Anca L. Grosu, Ursula Nestle
Precision Cancer Medicine  
2023;
6:
7  
Review Article 
Emerging drivers in non-small cell lung cancer, is there a role for immunotherapy?—a narrative review
Leonardo Brunetti, Valentina Santo, Marco Russano, Alessio Cortellini, Alessandro Galletti, Fabrizio Citarella, Giuseppina-Rita Di Fazio, Alessia Vendittelli, Giulia La Cava, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2023;
6:
6  
Review Article 
Lung cancer surgery in women: focus on gender-related outcomes—a narrative review
Carmelina C. Zirafa, Gaetano Romano, Elisa Sicolo, Andrea Castaldi, Federico Davini, Franca Melfi
Precision Cancer Medicine  
2023;
6:
5  
Review Article 
Favouring quality improvement initiatives: the experience of the Belgian College of Radiation Oncology
Aude Vaandering, Sarah Roels, Burak Yalvaç, Nathalie Reulens, Brigitte Reniers, Frederik Vanhoutte, Vincent Remouchamps, Yolande Lievens, Reinhilde Weytjens
Precision Cancer Medicine  
2023;
6:
4  
Original Article 
First-line ALK inhibitors in treatment-naive advanced ALK rearranged non-small cell lung cancer: systematic review and network meta-analysis
Aaron C. Tan, Sze Huey Tan, Mei-Kim Ang, Daniel S. W. Tan
Precision Cancer Medicine  
2023;
6:
3  
Editorial 
Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality
Alejandro Olivares-Hernández, José Pablo Miramontes-González, Juan Luis García Hernández, Edel del Barco Morillo, Emilio Fonseca-Sánchez
Precision Cancer Medicine  
2023;
6:
2  
Editorial 
Utility of intraparenchymal blood patch testing following CT-guided lung biopsy
Khezar Syed, Bryan S. Benn, Jonathan S. Kurman
Precision Cancer Medicine  
2023;
6:
1  
Case Report 
Gonadotropin releasing hormone agonist-related meningioma progression causing abducens nerve palsy: an oncological case report
Michael J. McKay, Ritwik Pandey, Hassan Zadeh, Kim Taubman
Precision Cancer Medicine  
2022;
5:
40  
Review Article 
Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review
Xiaoning Yu, Si Shi, Xianjun Yu
Precision Cancer Medicine  
2022;
5:
39  
Review Article 
Applications of generative adversarial networks (GANs) in radiotherapy: narrative review
Zhixiang Wang, Glauco Lorenzut, Zhen Zhang, Andre Dekker, Alberto Traverso
Precision Cancer Medicine  
2022;
5:
37  
Study Protocol 
Protocol: screening of genetic susceptibility genes for breast cancer patients and establishment of genetic high-risk populations cohort in east china communities
Zezhou Wang, Sanjian Yu, Xiaoshuang Feng, Xia Qiu, Hui Ji, Hailin Shan, Qing Shao, Heng Xia, Feng Cao, Jun Li, Cuixia Fu, Liqin Chen, Xiaofang Lu, Tingting Su, Qianqian Yu, Shengqun Hou, Honglian Wang, Yun Liu, Ying Zheng, Zhimin Shao, Zhen Hu
Precision Cancer Medicine  
2022;
5:
36  
Original Article 
Cancer incidence and mortality in Shanghai: rates in 2016 and trends from 2002 to 2016
Chunxiao Wu, Kai Gu, Yi Pang, Pingping Bao, Chunfang Wang, Liang Shi, Yangming Gong, Yongmei Xiang, Jianming Dou, Mengyin Wu, Yan Shi, Chen Fu
Precision Cancer Medicine  
2022;
5:
35  
Expert Consensus 
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
Precision Cancer Medicine  
2022;
5:
33  
Editorial 
Introduction to Management of Triple Negative Breast Cancer
Jacques Raphael
Precision Cancer Medicine  
2022;
5:
32  
Editorial 
Neuroimaging aspects and clinical significance of giant perivascular spaces in the brain
Giuseppe Barisano
Precision Cancer Medicine  
2022;
5:
31  
Editorial
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis
Case Report: Precision Oncology Tumor Board
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa